WHO WE ARE
NanoGenics is the leading company developing the artificial virus, a new kind of vector for gene therapy.
We have committed to overcoming the obstacle of delivery to fulfil the promise of gene therapy, working alongside innovative partners to bring cutting-edge treatments to market.
Read more about who we are...
WHAT WE DO
Introducing LipTide: The artificial virus
LipTide is a revolutionary nanoscale delivery vehicle invented to mimic a natural virus for targeted delivery of all forms DNA and RNA into cells.
With appealing clinical properties and the capability to deliver genetic material to almost any cell type, LipTide can help realise the potential of your gene therapy.
Read more about what we do...
Working with you
Every component of LipTide can be customised for purpose, offering unprecedented flexibility in target and payload.
Together, we can develop a bespoke research plan and create a LipTide solution to get your gene therapy from pipeline to patient.
Read more about working with you...
therapy treatments using LipTide are already in development in-house at NanoGenics.
An inhaled treatment
for cystic fibrosis
tumour growth suppressor
A novel glaucoma
INVESTING IN US
A visit from our Chief Scientific Officer and royalty in the same week. Why @edgehill University and its state-of-t… https://t.co/Fg6wtV0RCE
In his latest blog, our Chief Scientific Officer, @W12Newman explains why @edgehill University is the one to watch… https://t.co/KyMEvld30J
Animal studies have suggested amyotrophic lateral sclerosis #ALS can be prevented with #GeneTherapy - but delivery… https://t.co/WJEl1Uab8r